Patents by Inventor Benjamin Roa

Benjamin Roa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genes and gene signatures for diagnosis and treatement of melanoma
    Patent number: 11834719
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Grant
    Filed: May 20, 2021
    Date of Patent: December 5, 2023
    Assignee: MYRIAD MYPATH, LLC
    Inventors: Michael Bryan Warf, Benjamin Roa, Alexander Gutin, Darl Flake
  • GENES AND GENE SIGNATURES FOR DIAGNOSIS AND TREATMENT OF MELANOMA
    Publication number: 20230340615
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Application
    Filed: February 3, 2023
    Publication date: October 26, 2023
    Applicant: MYRIAD MYPATH, LLC
    Inventors: Michael Bryan WARF, Benjamin ROA, Alexander GUTIN, Darl FLAKE
  • Genes and gene signatures for diagnosis and treatment of melanoma
    Patent number: 11584967
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Grant
    Filed: February 10, 2020
    Date of Patent: February 21, 2023
    Assignee: MYRIAD MYPATH, LLC
    Inventors: Michael Bryan Warf, Benjamin Roa, Alexander Gutin, Darl Flake
  • GENES AND GENE SIGNATURES FOR DIAGNOSIS AND TREATEMENT OF MELANOMA
    Publication number: 20220098670
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Application
    Filed: May 20, 2021
    Publication date: March 31, 2022
    Applicant: MYRIAD MYPATH, LLC
    Inventors: Michael Bryan Warf, Benjamin Roa, Alexander Gutin, Darl Flake
  • Genes and gene signatures for diagnosis and treatment of melanoma
    Patent number: 11021752
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: June 1, 2021
    Assignee: Myriad Genetics, Inc.
    Inventors: Michael Bryan Warf, Benjamin Roa, Alexander Gutin, Darl Flake
  • GENES AND GENE SIGNATURES FOR DIAGNOSIS AND TREATMENT OF MELANOMA
    Publication number: 20200255908
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Application
    Filed: February 10, 2020
    Publication date: August 13, 2020
    Applicant: MYRIAD GENETICS, INC.
    Inventors: Michael Bryan WARF, Benjamin ROA, Alexander GUTIN, Darl FLAKE
  • Genes and gene signatures for diagnosis and treatment of melanoma
    Patent number: 10612099
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: April 7, 2020
    Assignee: Myriad Genetics, Inc
    Inventors: Michael Bryan Warf, Benjamin Roa, Alexander Gutin, Darl Flake
  • GENES AND GENE SIGNATURES FOR DIAGNOSIS AND TREATMENT OF MELANOMA
    Publication number: 20170198358
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Application
    Filed: December 22, 2016
    Publication date: July 13, 2017
    Inventors: Michael Bryan Warf, Benjamin Roa, Alexander Gutin, Darl Flake
  • GENES AND GENE SIGNATURES FOR DIAGNOSIS AND TREATMENT OF MELANOMA
    Publication number: 20140271546
    Abstract: Panels of biomarkers, methods and systems are disclosed for determining gene expression, and diagnosing and treating melanoma.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Inventors: Bryan Warf, Benjamin Roa, Alexander Gutin, Darl Flake
  • Method of assaying 5-FU
    Patent number: 8440442
    Abstract: The present invention provides methods, compositions, devices and kits for assaying 5-FU.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: May 14, 2013
    Assignee: Myriad Genetics, Inc
    Inventors: Benjamin Roa, Carrie Colvin, Michael Overfield, Howard McLeod, Salvatore Salamone
  • METHOD OF ASSAYING 5-FU
    Publication number: 20110034488
    Abstract: The present invention provides methods, compositions, devices and kits for assaying 5-FU.
    Type: Application
    Filed: July 19, 2010
    Publication date: February 10, 2011
    Applicant: Myriad Genetics, Incorporated
    Inventors: Benjamin Roa, Carrie Colvin, Michael Overfield, Howard McLeod, Salvatore Salamone
  • METHOD OF DETECTING LARGE GENOMIC REARRANGEMENTS
    Publication number: 20100035261
    Abstract: A method for detecting large genomic rearrangements is disclosed, which is particularly useful in detecting deletions and duplications in the large genes such as BRCA1, BRCA2, MLH1 and MSH2.
    Type: Application
    Filed: May 18, 2009
    Publication date: February 11, 2010
    Applicant: Myriad Genetics, Incorporated
    Inventors: Thomas Scholl, Thaddeus Judkins, Brant Hendrickson, Benjamin Roa, Carrie Colvin
  • Automatic configuration system which analyzes HDLC flag data in TDM time slots for determining which time slot(s) is dedicated for frame relay service
    Patent number: 6493352
    Abstract: Disclosed is an automatic configuration system and method for automatically configuring the time slots on a time division multiplexing connection line that is dedicated for frame relay service. Generally, the system and method described involve the determination of potential dedicated time slots configured at the central office for frame relay traffic. Next, a level of confidence is determined regarding the potential dedicated time slots. If the level of confidence is high, then the system attempts to establish a local management interface with the central office frame relay switch, service, or similar device over the potential dedicated time slots. Once the local management interface is established using the potential dedicated time slots, then these time slots are stored as the new configuration for frame relay traffic by the frame relay DSU.
    Type: Grant
    Filed: July 16, 1998
    Date of Patent: December 10, 2002
    Assignee: Paradyne Corporation
    Inventors: Ted Nodine Mawhinney, Luis Benjamin Roa